Metraipolis › archive › dc_74c83863c552
Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors — Europe PMC PMID:41350408
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41350408
- DOI
- 10.1038/s41598-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:40:58.182Z
- SHA-256 of the archived text
ed7eb7055c3ddd4a49308e58bdc4465f6deca4c00e3519a586e11aeb5740d424- Stable URL of this page
https://metraipolis.com/documento/dc_74c83863c552
How to cite
Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors — Europe PMC PMID:41350408 — Europe PMC (en), https://europepmc.org/article/MED/41350408 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74c83863c552 (Metraipolis archive dc_74c83863c552, sha256 ed7eb7055c3ddd4a49308e58bdc4465f6deca4c00e3519a586e11aeb5740d424)
BibTeX
@misc{dc74c83863c552,
title = {Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors — Europe PMC PMID:41350408},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41350408},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74c83863c552; sha256 ed7eb7055c3ddd4a49308e58bdc4465f6deca4c00e3519a586e11aeb5740d424},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41350408. Agents can read the archived copy with the MCP tool read_document.